Cronos Group Inc. (CRON) announced strong third-quarter 2024 results, driven by robust cannabis flower and extract sales in Canada, Israel, and international markets. The company also highlighted its strategic expansion of Cronos GrowCo, its 50%-owned cannabis cultivation subsidiary, and its commitment to cost savings and profitable growth.